Page last updated: 2024-11-03

probenecid and Actinomycosis, Cervicofacial

probenecid has been researched along with Actinomycosis, Cervicofacial in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Actinomycosis, Cervicofacial: A form of ACTINOMYCOSIS characterized by slow-growing inflammatory lesions of the lymph nodes that drain the mouth (lumpy jaw), reddening of the overlying skin, and intraperitoneal abscesses.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silbermann, M1
Chiminello, FJ1
Doku, HC1
Maloney, PL1
Caldwell, JL1

Other Studies

2 other studies available for probenecid and Actinomycosis, Cervicofacial

ArticleYear
Mandibular actinomycosis: report of case.
    Journal of the American Dental Association (1939), 1975, Volume: 90, Issue:1

    Topics: Actinomyces; Actinomycosis, Cervicofacial; Adult; Alcoholism; Anesthesia, Local; Female; Fracture Fi

1975
Actinomycosis treated with cephalothin.
    Southern medical journal, 1971, Volume: 64, Issue:8

    Topics: Actinomycosis, Cervicofacial; Adult; Cephalothin; Female; Humans; Hydrocortisone; Infusions, Parente

1971